Placement Completed

Silence Therapeutics placement

US$201m raised

NASDAQ: SLN

Advisers

Silence Therapeutics

Issuer

Not disclosed

Lead managers

Legal adviser
Issuer
Silence Therapeutics
Issuer based in
United Kingdom (unverified)
Completed
17 Aug 2026
Sector
Biotech
Tags
Biotech, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.